ARCHIVES

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996

CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development

August 24, 1979

Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal

June 18, 1982